Skip to main content
. 2021 May 10;13(9):2273. doi: 10.3390/cancers13092273

Figure 5.

Figure 5

(A). Heteroplasmic levels in all malignant tissue samples (n = 15) only. (A) Heteroplasmy count and (B) heteroplasmy levels in low vs. high SUVmax subgroups. No statistically significant difference between low (n = 8) and high SUVmax groups (n = 7) could be observed. (C) MutPred pathogenicity score of mutations leading to amino-acid alterations in high- vs. low-SUVmax subgroups.